Loading...
Alogliptin-Induced Minimal Change Nephrotic Syndrome and Interstitial Nephritis
Alogliptin is one of the dipeptidyl peptidase-4 inhibitors used to treat patients with type 2 diabetes. Little is known about the nephrotoxicity associated with alogliptin, such as nephrotic syndrome or interstitial nephritis. We report a biopsy-proven rare case of minimal change nephrotic syndrome...
Na minha lista:
| Udgivet i: | Kidney Med |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Elsevier
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7380391/ https://ncbi.nlm.nih.gov/pubmed/32734188 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.xkme.2019.03.001 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|